TABLE 4

Ratio of the accumulation of folate-DTPA-In111 in tumors to tissue as a function of injection frequency

Tumor-bearing mice were injected at different time intervals with a saturating dose of folate-DTPA-111In, and all mice were administered the conjugate at 40 h. Values are representative of three experiments (five mice per group). Injection times were: 1× at 40 h; 2× at 0 and 40 h; 3× at 0, 20, and 40 h; 4× at 0, 13.3, 26.6, and 40; 6× at 0, 8, 16, 24, 32, and 40 h; and 8× at 0, 5.7, 11.4, 17.1, 22.8, 28.5, 34.2, and 40 h.

Number of Injections in 40 h
1 2 3 4 6 8
% injected dose, g of tumor:g of normal tissue
M109
Liver 11.4 11.9 7.33 5.52 2.97 3.96
Kidney 0.739 0.5 0.349 0.321 0.272 0.211
Muscle 12.3 20.1 12.6 5.96 5.76 10.6
Blood 151 130 121 62.6 31.6
Line 01
Liver 15.6 14.9 11.4 8.92 5.33 1.86
Kidney 0.5 0.57 0.39 0.33 0.27 0.12
Muscle 5.05 37.8 20.7 13.1 14.8 3.29
Blood 123 127 148 68.2 53.3 6.9
L1210A
Liver 7.44 5.75 4.15 11.7 7.89 1.94
Kidney 1.32 1.63 1.15 1.26 1.12 1.2
Muscle 16.7 10.4 11.1 20.5 20.5 29.1
Blood 380 156 111 90.7 66.9 52.4